Clinical Trials Browser

Active not recruiting × Breast Cancer Invasive × Surgical Procedures, Operative × Clear all

NCT04398914 2022-03-31

Pyrotinib, Trastuzumab, Pertuzumab and Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer

Phase 2 Active not recruiting

Breast Cancer Invasive